Amasil formic acid approved for US poultry market

 

NEW HAMPTON, NY, and FLORHAM PARK, NJ, January 3, 2017 -- BASF and Balchem Corporation (NASDAQ:BCPC) received FDA approval to launch Amasil® formic acid in poultry diets in the United States.Amasil was recently introduced in the U.S. for swine, and has been successfully used in poultry diets around the world. It is considered the most potent organic acid for feed acidification.

By lowering the feed pH, Amasil creates a less favorable environment for bacteria, which reduces feed-borne pathogen populations and decreases microbial intake. A reduction in pH also lowers the buffering capacity, which can improve the efficacy of many digestive enzymes and lead to improved feed efficiency and growth.

"With the highest molecular density of any organic acid approved in the U.S., Amasil provides a best in class value for feed acidification," said Christian Nitschke, BASF Regional Head, Animal Nutrition North America. "With Balchem, we can now deliver the benefits of Amasil to poultry and pork producers throughout North America."

"We are excited about this new opportunity to impact feed efficiency and growth for our poultry customers," notes Tom Powell, Director of Monogastrics, Balchem Animal Nutrition & Health. "Amasil delivers the feed hygiene benefits we need to meet consumer demands for a safe food supply."

Poultry producers and industry leaders can learn more about Amasil at the 2017 International Production and Processing Expo (IPPE) held in Atlanta, Georgia, January 31 through February 2, 2017. To register for the Amasil Poultry Launch Event prior to IPPE, contact Balchem by email at anh@balchem.com.

About Balchem Corporation
Balchem Corporation (NASDAQ: BCPC) consists of four business segments: Human Nutrition & Health (formerly SensoryEffects); Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications. For more information, visit www.balchem.com.

About BASF
BASF Corporation, headquartered in Florham Park, New Jersey, is the North American affiliate of BASF SE, Ludwigshafen, Germany. BASF has nearly 17,500 employees in North America, and had sales of $17.4 billion in 2015. For more information about BASF's North American operations, visit www.basf.us.

At BASF, we create chemistry for a sustainable future. We combine economic success with environmental protection and social responsibility. The approximately 112,000 employees in the BASF Group work on contributing to the success of our customers in nearly all sectors and almost every country in the world. Our portfolio is organized into five segments: Chemicals, Performance Products, Functional Materials & Solutions, Agricultural Solutions and Oil & Gas. BASF generated sales of more than €70 billion in 2015. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA) and Zurich (AN). Further information at www.basf.com.

Media Inquiries:

Balchem Contact:
Scott Sorrell, Director, Global Species Mktg
Tel.: (845) 326-5603
Email: ssorrell@balchem.com

BASF Contact:
Tony Graetzer, Marketing Communications
Tel.: (973) 245-7960
Email: tony.graetzer@partners.basf.com

 

 

+